Group 1 - Tevogen Bio Holdings Inc. has received inquiries from shareholders about transferring shares to the Direct Registration System (DRS) following a recent press release [1] - The company will provide step-by-step guidance next week for shareholders to register their shares directly with the transfer agent, Continental Stock Transfer & Trust [2] - Several of Tevogen's largest shareholders have chosen to hold their shares via DRS, indicating their confidence in this method of ownership [2]

Core Viewpoint - Tevogen Bio Holdings Inc. informs shareholders about the differences between holding shares in Direct Registration System (DRS) accounts versus brokerage accounts, highlighting the benefits and drawbacks of each option [1]. Group 1: DRS Accounts - DRS accounts allow shares to be registered directly in the shareholder's name, providing direct control over the shares [2]. - Holding shares in DRS accounts may result in reduced transaction and account maintenance costs for shareholders [2]. Group 2: Brokerage Accounts - Brokerage accounts may offer greater access to investment tools and facilitate quicker selling of shares compared to DRS accounts [2]. - Investors may incur costs associated with transferring shares in and out of brokerage accounts [2]. Group 3: Additional Information - For further details regarding the differences between DRS and brokerage accounts, shareholders are encouraged to contact the Company's transfer agent, Continental Stock Transfer & Trust [3].